OBSTRUCTIVE SLEEP APNEA AND CHRONIC KIDNEY DISEASE: AN ANALYTICAL REVIEW
https://doi.org/10.17802/2306-1278-2026-15-1-97-108
Abstract
Highlights
The data of domestic and foreign sources on the relationship between obstructive sleep apnea syndrome and chronic kidney disease are analyzed and presented. The features of clinical manifestations of obstructive sleep apnea syndrome in patients with chronic kidney disease are shown. The protective effect of CPAP therapy on kidney function is highlighted.
Abstract
Obstructive sleep apnea syndrome (OSA) and chronic kidney disease (CKD) are clinically significant diseases with high comorbidity, potentiating the risk of developing cardiovascular complications. The prevalence of these pathological conditions is progressively increasing. At the same time, the problem of association between OSA and CKD is underestimated and quite relevant. The review article presents the features of the clinical course of OSA in patients with CKD, as well as the main pathophysiological mechanisms influencing the relationship between OSA and CKD. The role of CPAP (Continuous Positive Airway Pressure, CPAP) therapy in reducing the risk of CKD progression and complications is shown.
About the Authors
Larisa G. Evlampieva
Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science
Russian Federation
Russian Federation
PhD, Junior Researcher at the Laboratory of Instrumental Diagnostics, Department of Instrumental Research Methods, Tyumen Cardiology Research Center, Branch of Tomsk National Research Medical Center, Tyumen, Russian Federation
Vsevolod E. Kharats
Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science
Russian Federation
Russian Federation
PhD, Head of the Department of Surgical Treatment of Complex Heart Rhythm Disorders and Pacing, Senior Researcher at the Laboratory of Instrumental Diagnostics, Department of Instrumental Research Methods, Tyumen Cardiological Research Center, Branch of Tomsk National Research Medical Center, Tyumen, Russian Federation
Elena I. Yaroslavskaya
Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science
Russian Federation
Russian Federation
PhD, Leading Researcher, Head of Laboratory of Instrumental Diagnostics, Department of Instrumental Research Methods, Tyumen Cardiological Research Center, Branch of Tomsk National Research Medical Center, Tyumen, Russian Federation
References
1. Jager K.J., Kovesdy C., Langham R., Rosenberg M., Jha V., Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant. 2019;34(11):1803-1805. doi: 10.1093/ndt/gfz174
2. Hill N.R., Fatoba S.T., Oke J.L., Hirst J.A., O'Callaghan C.A., Lasserson D.S., Hobbs F.D. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016;6;11(7):e0158765. doi: 10.1371/journal.pone.0158765
3. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990—2017: a systematic analysis for the Global Burden of Disease 2017. Lancet. 2020;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3
4. Foreman K.J., Marquez N., Dolgert Foreman K.J., Marquez N., Dolgert A., Fukutaki K., Fullman N., McGaughey M., Pletcher M.A., Smith A.E., Tang K., Yuan C.W., Brown J.C., Friedman J., He J., Heuton K.R., Holmberg M., Patel D.J., Reidy P., Carter A., Cercy K., Chapin A., Douwes-Schultz D., Frank T., Goettsch F., Liu P.Y., Nandakumar V., Reitsma M.B., Reuter V., Sadat N., Sorensen R.J.D., Srinivasan V., Updike R.L., York H., Lopez A.D., Lozano R., Lim S.S., Mokdad A.H., Vollset S.E., Murray C.J.L. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5
5. Rzhevskaya O.N., Moiseyeva A.Y., Esaulenko A.N., Pinchuk A.V., Alidzhanova Kh.G. Chronic Kidney Disease and Myocardial Infarction. Russian Sklifosovsky Journal "Emergency Medical Care". 2022;11(1):104-118. (In Russ.) doi: 10.23934/2223-9022-2022-11-1-104-118
6. Tkacheva O.N., Kotovskaya Yu. V., Bobkova I.N., Shutov A.M., Villevalde S.V., Efremova E.V., Runikhina N.K., Eruslanova K.A., Arutyunov G.P., Batyushin M.M. Frolova Е.V. Chronic Kidney Disease in Older Adults. Consensus Statement of Russian Association of Gerontologists and Geriatricians, Scientific Society of Nephrologists of Russia and Eurasian Association of Therapists. Russian Journal of Geriatric Medicine. 2024;1(17):6–20. (In Russ.) doi: 10.37586/2686-8636-1-2024-6-20
7. Francis A., Harhay M.N., Ong A.C.M., Tummalapalli S. L., Ortiz A., Fogo A.B., Fliser D., Roy-Chaudhury P., Fontana M., Nangaku M., Wanner C., Malik C., Hradsky A., Adu D., Bavanandan S., Cusumano A., Sola L., Ulasi I , Jha V. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 2024;20:473–485. doi:10.1038/s41581-024-00820-6
8. Beaudin A.E., Raneri J.K., Ahmed S.B., Hirsch Allen A.J.M., Nocon A., Gomes T., Gakwaya S., Series F., Kimoff J., Skomro R.P., Ayas N.T., Hanly P.J. Risk of chronic kidney disease in patients with obstructive sleep apnea. Sleep. 2022;45(2):zsab267. doi: 10.1093/sleep/zsab267
9. Chou Y.T., Lee P.H., Yang C.T., Lin C.L., Veasey S., Chuang L.P., Lin S.W., Lin Y.S., Chen N.H. Obstructive sleep apnea: a stand-alone risk factor for chronic kidney disease. Nephrol Dial Transplant. 2011;26(7):2244-2250. doi: 10.1093/ndt/gfq821
10. Kanbay A., Buyukoglan H., Ozdogan N., Kaya E., Oymak F.S., Gulmez I., Demir R., Kokturk O., Covic A. Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease. Int Urol Nephrol. 2012;44(2):535-9. doi: 10.1007/s11255-011-9927-8
11. Benjafield A.V., Ayas N.T., Eastwood P.R., Heinzer R., Ip M.S.M., Morrell M.J., Nunez C.M., Patel S.R., Penzel T., Pépin J.L., Peppard P.E., Sinha S., Tufik S., Valentine K., Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5
12. Khokhrina A., Andreeva E., Degryse J.M. The prevalence of sleep-disordered breathing in Northwest Russia: The ARKHsleep study. Chron Respir Dis. 2020;17:1479973120928103. doi: 10.1177/1479973120928103
13. Pisano A., Zoccali C., Bolignano D., D'Arrigo G., Mallamaci F. Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis. Clin Kidney J. 2023;17(1):sfad179. doi: 10.1093/ckj/sfad179
14. Kuhlmann U., Becker H.F., Birkhahn M., Peter J.H., von Wichert P., Schütterle S., Lange H. Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol. 2000;53(6):460-6.
15. Lavoie M.R., Patel J.A., Camacho M. Nocturnal dialysis improves sleep apnea more than daytime dialysis: a meta-analysis of crossover studies. Sleep Medicine. 2019;64:37-42. doi: 10.1016/j.sleep.2019.06.005
16. Hui M., Li Y., Ye J., Zhuang Z., Wang W. Obstructive sleep apnea-hypopnea syndrome (OSAHS) comorbid with diabetes rather than OSAHS alone serves an independent risk factor for chronic kidney disease (CKD). Ann Palliat Med 2020;9(3):858-869. doi: 10.21037/apm.2020.03.21
17. Beaudin A.E., Raneri J.K., Ahmed S.B., Hirsch Allen AJM., Nocon A., Gomes T., Gakwaya S., Series F., Kimoff J., Skomro R.P., Ayas N.T., Hanly P.J. Risk of chronic kidney disease in patients with obstructive sleep apnea. Sleep. 2022;45(2):zsab267. doi: 10.1093/sleep/zsab267
18. Lin Y.S., Liu P.H., Lin S.W., Chuang L.P., Ho W.J., Chou Y.T., Juan K.C., Lo M.T., Chu P.H., Chen N.H. Simple obstructive sleep apnea patients without hypertension or diabetes accelerate kidney dysfunction: a population follow-up cohort study from Taiwan. Sleep Breath. 2017;21(1):85-91. doi: 10.1007/s11325-016-1376-2
19. Liu T., Zhan Y., Wang Y., Li Q., Mao H. Obstructive sleep apnea syndrome and risk of renal impairment: a systematic review and meta-analysis with trial sequential analysis. Sleep Breath. 2021;25(1):17-27. doi: 10.1007/s11325-020-02090-5
20. Yayan J., Rasche K., Vlachou A. Obstructive Sleep Apnea and Chronic Kidney Disease. Adv Exp Med Biol. 2017;1022:11-18. doi: 10.1007/5584_2017_35
21. Evlampieva L.G., Kharats V.E., Guskova O.A., Sergeichik O.I., Shirokov N.E., Stallings A.D., Gorbatenko E.A., Yaroslavskaya E.I. Prediction of adherence to CPAP therapy in cardiac patients. Complex Issues of Cardiovascular Diseases. 2024;13(3):130-143. (In Russ.) doi: 10.17802/2306-1278-2024-13-3-130-143
22. Gansevoort R.T., Correa-Rotter R., Hemmelgarn B.R., Jafar T.H., Heerspink H.J., Mann J.F., Matsushita K., Wen C.P. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339-52. doi: 10.1016/S0140-6736(13)60595-4
23. Cozzolino M., Mangano M., Stucchi A., Ciceri P., Conte F., Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33(suppl_3):iii28-iii34. doi: 10.1093/ndt/gfy174
24. Watanabe Y., Tanaka A., Furuhashi K., Saito S., Maruyama S. Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease and Sleep Apnea Syndrome. Front Med (Lausanne). 2022;9:899359. doi: 10.3389/fmed.2022.899359
25. Jamwal J., Qadri S.M., Siraj F., Shah S. Prevalence of obstructive sleep apnea in patients with chronic kidney disease: a hospital-based study. Sleep Breath. 2023;27(5):1703-1708. doi: 10.1007/s11325-022-02764-2
26. Jhamb M., Ran X., Abdalla H., Roumelioti M.E., Hou S., Davis H., Patel S.R., Yabes J., Unruh M. Association of Sleep Apnea with Mortality in Patients with Advanced Kidney Disease. Clin J Am Soc Nephrol. 2020;15(2):182-190. doi: 10.2215/CJN.07880719
27. Berry R.B., Budhiraja R., Gottlieb D.J., Gozal D., Iber C., Kapur V.K., Marcus C.L., Mehra R., Parthasarathy S., Quan S.F., Redline S., Strohl K.P., Davidson Ward S.L., Tangredi M.M. American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597-619. doi: 10.5664/jcsm.2172
28. Buzunov R.V., Palman A.D., Melnikov A.Yu., Averbukh V.M., Madayeva I.M., Kulikov A.N. Diagnostics and Treatment of Obstructive Sleep Apnea Syndrome in Adults. Recommendations of the Russian Society of Sleep Medicine. Effective pharmacotherapy. Neurology Special issue "Sleep and its disorders - 6". 2018;35:34-45. (In Russ.).
29. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018
30. Sircu V., Colesnic S.I., Covantsev S., Corlateanu O., Sukhotko A., Popovici C., Corlateanu A. The Burden of Comorbidities in Obstructive Sleep Apnea and the Pathophysiologic Mechanisms and Effects of CPAP. Clocks Sleep. 2023; 5(2):333-349. doi: 10.3390/clockssleep5020025
31. Efremova E.V., Shutov A.M., Serov V.A. Obstructive sleep apnea syndrome in elderly and senile patients with chronic kidney disease. Therapy. 2021;3:36-42. (In Russ.) doi: 10.18565/therapy.2021.3.36-42
32. Somkearti P., Chattakul P., Khamsai S., Limpawattana P., Chindaprasirt J., Chotmongkol V., Sawanyawisuth K. Predictors of chronic kidney disease in obstructive sleep apnea patients. Multidiscip Respir Med. 2020;15(1):470. doi: 10.4081/mrm.2020.470
33. Bormina S.O., Korostovtseva L.S., Bochkarev M.V., Sviryaev Y.V., Konradi A.O., Tikhonenko V.M. Multifunctional Monitoring: is it Possible to Simultaneously Evaluate Blood Pressure and Sleep-Disordered Breathing? Kardiologiia. 2020;60(1):10–15. (In Russ.) doi: 10.18087/cardio.2020.1.n482
34. Kuzmin O.B., Zhezha V.V., Belyanin V.V., Buchneva N.V. Effect of chronic kidney disease on the formation of diastolic heart dysfunction in heart failure patients with preserved ejection fraction. Kardiologiia. 2018;58(4S):37-45. (In Russ.) doi: 10.18087/cardio.2451
35. Krupichka K.S., Agaltsov M.V., Beregovskaya S.A., Myasnikov R.P., Drapkina O.M. Sleep-related breathing disorders in patients with heart failure with reduced and mildly reduced ejection fraction: main types and their dependence on heart failure etiology. Russian Journal of Cardiology. 2023;28(1S):5261. (In Russ.) doi: 10.15829/1560-4071-2023-5261
36. Alidzhanova K.G., Rzhevskaya O.N., Sagirov M.A., Gazaryan G.A. Prognostic importance of chronic kidney disease in patients with acute coronary syndrome. Russian Sklifosovsky Journal «Emergency Medical Care». 2017;6(2):132-139. (In Russ.) doi: 10.23934/2223-9022-2017-6-2132-139
37. Osipova O.A., Gosteva E.V., Zhernakova N.I., Shepel R.V., Ponomarenko T.N., Inshakova K.Yu., Drapkina O.M. 24-hour blood pressure profile and systemic inflammation in patients with stable coronary artery disease with obstructive sleep apnea. Cardiovascular Therapy and Prevention. 2023;22(9):3705. (In Russ.) doi: 10.15829/1728-8800-2023-3705
38. Zamarrón E., Jaureguizar A., García-Sánchez A., Díaz-Cambriles T., Alonso-Fernández A., Lores V., Mediano S.A.O., Rodriguez-Rodriguez P., Cabello Pelegrin S., Morales-Ruiz E., Ramirez-Prieto M.T., Isabel Valiente-Diae M., Gomez-Garcia T., Gargia-Rio F., Spanish Sleep N. Obstructive sleep apnea is associated with impaired renal function in patients with diabetic kidney disease. Sci Rep. 2021;11(1):5675. doi: 10.1038/s41598-021-85023-w
39. Hui M, Li Y, Ye J, Zhuang Z, Wang W. Obstructive sleep apnea-hypopnea syndrome (OSAHS) comorbid with diabetes rather than OSAHS alone serves an independent risk factor for chronic kidney disease (CKD). Ann Palliat Med. 2020;9(3):858-869. doi: 10.21037/apm.2020.03.21
40. Yayan J., Rasche K. A Systematic Review of Risk factors for Sleep Apnea. Prev Med Rep. 2024;42:102750. doi: 10.1016/j.pmedr.2024.102750
41. Yin T., Chen Y., Tang L., Yuan H., Zeng X., Fu P. Relationship between modifiable lifestyle factors and chronic kidney disease: a bibliometric analysis of top-cited publications from 2011 to 2020. BMC Nephrol. 2022;23(1):120. doi: 10.1186/s12882-022-02745-3
42. Hwu D.W., Lin K.D., Lin K.C., Lee Y.J., Chang Y.H. The association of obstructive sleep apnea and renal outcomes-a systematic review and meta-analysis. BMC Nephrology. 2017;18(1):313. doi: 10.1186/s12882-017-0731-2
43. Adams R.J., Appleton S.L., Vakulin A., Hanly P.J., McDonald S.P., Martin S.A., Lang C.J., Taylor A.W., McEvoy R.D., Antic N.A., Catcheside P.G., Vincent A.D., Wittert G.A. Chronic Kidney Disease and Sleep Apnea Association of Kidney Disease With Obstructive Sleep Apnea in a Population Study of Men. Sleep. 2017;40(1). doi: 10.1093/sleep/zsw015
44. So J.Y., Warburton K.M., Rosen I.M. A Guide to Management of Sleepiness in ESKD. Am J Kidney Dis. 2020;75(5):782-792. doi: 10.1053/j.ajkd.2019.09.010
45. Koh J.H., Lim C.Y.J., Yam K.J.M., Yeo B.S.Y., Ng A.C.W., Loh S.R.H., Hsu P.P., Gooley J., Tan C.S., Toh S.T. Bidirectional association of sleep disorders with chronic kidney disease: a systematic review and meta-analysis. Clin Kidney J. 2024;17(11):sfae279. doi: 10.1093/ckj/sfae279
46. Theofilou P. Association of insomnia symptoms with kidney disease quality of life reported by patients on maintenance dialysis. Psychol Health Med. 2013;18(1):70-8. doi: 10.1080/13548506.2012.674144
47. Maung S.C., El Sara A., Chapman C., Cohen D., Cukor D. Sleep disorders and chronic kidney disease. World J Nephrol. 2016;5(3):224-232. doi: 10.5527/wjn.v5.i3.224
48. Nicholl D.D., Ahmed S.B., Loewen A.H., Hemmelgarn B.R., Sola D.Y., Beecroft J.M., Turin T.C., Hanly P.J. Clinical presentation of obstructive sleep apnea in patients with chronic kidney disease. J Clin Sleep Med. 2012;8(4):381-7. doi: 10.5664/jcsm.2028
49. Parker K.P., Bliwise D.L., Bailey J.L., Rye D.B. Daytime sleepiness in stable hemodialysis patients. Am J Kidney Dis. 2003;41(2):394-402. doi: 10.1053/ajkd.2003.50049
50. Jean G., Piperno D., François B., Charra B. Sleep apnea incidence in maintenance hemodialysis patients: influence of dialysate buffer. Nephron. 1995;71(2):138-42. doi: 10.1159/000188701
51. Pressman M., Benz R.L., Schleifer CR., Peterson D.D. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int. 1993;43(5):1134-9. doi: 10.1038/ki.1993.159
52. Beecroft J.M., Pierratos A., Hanly P.J. Clinical presentation of obstructive sleep apnea in patients with end-stage renal disease. J Clin Sleep Med. 2009;5(2):115-121.
53. Abuvassin B., Sharma K., Ayas N.T. Laher I. Obstructive sleep apnea and kidney disease: a potential bidirectional relationship? J Clin Sleep Med. 2015;11(8):915–924. doi: 10.5664/jcsm.4946
54. Oksenyuk O.S., Kalmykova Yu.A., Smirnova O.B., Pasechnik D.G. The role of oxidative stress in the development of kidney diseases and methods of its assessment. Journal of Fundamental Medicine and Biology. 2016;1:15-24. (In Russ.).
55. Kuzmin O.B. Chronic kidney disease: mechanisms of hypoxic glomerulosclerosis and tubulointerstitial fibrosis development and progression. Nephrology (Saint-Petersburg). 2015;19(4):6-16. (In Russ.).
56. Reznik E.V., Nikitin I.G. Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment. The Russian Archives of Internal Medicine. 2019;9(2):93-106. (In Russ.) doi: 10.20514/2226-6704-2019-9-2-93-106
57. Zelveian P.A., Dgerian L.G. The main pathophysiologigal mechanisms of kidney injury in obstructive sleep apnea syndrome. Therapeutic archive. 2014;86(6):100-105. (In Russ.).
58. Drapkina О.M., Dubolazova Yu.V., Korneeva О.N. Obstructive sleep apnea as cardiovascular risk factor: to treat or not? Cardiovascular Therapy and Prevention. 2017;16(3):68-74. (In Russ.) doi: 10.15829/1728-8800-2017-3-68-74
59. Krieger J., Follenius M., Sforza E., Brandenberger G., Peter J.D. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond). 1991;80(5):443-9. doi: 10.1042/cs0800443
60. Kara T., Narkiewicz K., Somers V.K. Chemoreflexes-physiology and clinical implications. Acta Physiol Scand. 2003;177(3):377-84. doi: 10.1046/j.1365-201X.2003.01083.x
61. Kimoff R.J. Upperairway myopathy is important in the pathophysiology of obstructive sleep apnea. J Clin Sleep Med. 2007;3(6):567-9.
62. Mavanur M., Sanders M., Unruh M. Sleep disordered breathing in patients with chronic kidney disease. Indian J Med Res. 2010;131:277-84.
63. Puckrin R., Iqbal S., Zidulka A., Vasilevsky M., Barre P. Renoprotective effects of continuous positive airway pressure in chronic kidney disease patients with sleep apnea. Int Urol Nephrol. 2015;47(11):1839-45. doi: 10.1007/s11255-015-1113-y
64. Voulgaris A., Marrone O., Bonsignore M.R., Steiropoulos P. Chronic kidney disease in patients with obstructive sleep apnea. A narrative review. Sleep Med Rev. 2019;47:74-89. doi: 10.1016/j.smrv.2019.07.001
65. Li X., Liu C., Zhang H., Zhang J., Zhao M., Sun D., Xia M., Han M. Effect of 12-month nasal continuous positive airway pressure therapy for obstructive sleep apnea on progression of chronic kidney disease. Medicine (Baltimore). 2019;98(8):e14545. doi: 10.1097/MD.0000000000014545
66. Parmaksız E., Torun Parmaksız E. Reversibility of microalbuminuria with continuous positive airway pressure treatment in obstructive sleep apnea syndrome. Int Urol Nephrol. 2020;52(9):1719-1724. doi: 10.1007/s11255-020-02519-6
67. Perticone M., Maio R., Scarpino P.E., Mancuso L., Volpentesta M., Caroleo B., Suraci E., Sciacqua A., Sesti G., Perticone F. Continuous Positive Airway Pressure Improves Renal Function in Obese Patients With Obstructive Sleep Apnea Syndrome. Front Med (Lausanne). 2021;8:642086. doi: 10.3389/fmed.2021.642086
68. Chen R., Huang Z.W., Lin X.F., Lin J.F., Yang M.J. Effect of continuous positive airway pressure on albuminuria in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath. 2022;26(1):279-285. doi: 10.1007/s11325-021-02393-1
69. Statsenko M.E., Talagayev S.V. Effect of assisted ventilation with positive pressure on the daily blood pressure and renal function in patients with obstructive sleep apnea syndrome and hypertension. Journal of Volgograd State Medical University. 2015;12(2):116-119. (In Russ.).
70. Pochetti P., Azzolina D., Ragnoli B., Tillio P.A., Cantaluppi V., Malerba M. Interrelationship among Obstructive Sleep Apnea, Renal Function and Survival: A Cohort Study. Int J Environ Res Public Health. 2020;17(14):4922. doi: 10.3390/ijerph17144922
71. Nicholl D.D.M., Hanly J., Zalucky A.A., Handley G.B., Sola D.Y., Ahmed S.B. Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin-angiotensin-aldosterone system activity in humans with obstructive sleep apnea. Sleep. 2021;44(5):zsaa228. doi: 10.1093/sleep/zsaa228
72. Hanly P.J., Ahmed S., Fjell C.D., Handley G.B., Sola D., Nicholl D., Zalucky A. Urine biomarkers of renal renin-angiotensin system activity: Exploratory analysis in humans with and without obstructive sleep apnea. Physiol Rep. 2020;8(6):e14376. doi: 10.14814/phy2.14376
73. Zhang L., Huang X., Li X., Wu Q. Alterations in renal function in patients with obstructive sleep apnea syndrome and effects of continuous positive airway pressure. Chin Med J (Engl). 1997;110(12):915-8.
74. Jin F., Liu J., Zhang X., Cai W., Zhang Y., Zhang W., Yang J., Lu G., Zhang X. Effect of continuous positive airway pressure therapy on inflammatory cytokines and atherosclerosis in patients with obstructive sleep apnea syndrome. Mol Med Rep. 2017;16(5):6334-6339. doi: 10.3892/mmr.2017.7399
75. Li C., Zhang X.L., Liu H., Wang Z.G., Yin K.S. Association among plasma interleukin-18 levels, carotid intima- media thickness and severity of obstructive sleep apnea. Chin Med J (Engl). 2009;122(1):24-9
76. Petrichshev N.N., Achkasova V.V., Mnuskina M.M., Smirnov A.V., Panina I.Yu., Rumyantsev A.Sh., Menshutina M.A. Reactivity of microcirculation skin vessels during the distant cold influence and concentration of endotelin-1 in chronic kidney disease. Regional blood circulation and microcirculation. 2011;10(4):59-64. (In Russ.) doi: 10.24884/1682-6655-2011-10-4-59-64
77. Lin G., Chen Q., Huang J., Chen L., Lin T., Lin Q. Effect of continuous positive airway pressure on endothelin-1 in patients with obstructive sleep apnea: a meta-analysis. Eur Arch Otorhinolaryngol. 2019;276(3):623-630. doi: 10.1007/s00405-018-5225-8
78. Shakhmalova M.Sh., Kurumova K.O., Klefortova I.I., Sitkin I.I., Ilyin A.V., Arbuzova M.I., Gorcharov N.P., Katsiya G.V., Aleksandrov A.A., Kukharenko S.S., Shestakova M.V., Dedov I.I. Factors promoting development of renal tubulointerstitial lesions in patients with diabetes mellitus. Diabetes mellitus. 2010;13(3):134-141. (In Russ.) doi: 10.14341/2072-0351-5502
79. Celik Y., Jelic S., Behboudi A. CPAP Reduces Circulating Vascular Endothelial Growth Factor Levels in Patients with Coronary Artery Disease and Obstructive Sleep Apnoea:The RICCADSA Trial. European Respiratory Journal. 2023;62(suppl 67):ОА3286. doi: 10.1183/13993003.congress-2023.OA3286
80. Ip M.S., Lam B., Chan L.Y., Zheng L., Tsang K.W., Fung P.C., Lam W.K. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162(6):2166-71. doi: 10.1164/ajrccm.162.6.2002126
81. Güngördü N., Börekçi Ş., Çulpan H.C., Coşkun E., Ayan F., Mutlu B. Effect of continuous positive airway pressure therapy on pro-brain natriuretic peptide, C-reactive protein, homocysteine, and cardiac marker in patients with obstructive sleep apnea. Thorac. Res. Pract. 2023;24(2):76-84. doi: 10.5152/ThoracResPract.2023.22130
82. Lin C.C. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Eur Respir J. 1994;7(11):2005-2010.
Review
For citations:
Evlampieva L.G., Kharats V.E., Yaroslavskaya E.I. OBSTRUCTIVE SLEEP APNEA AND CHRONIC KIDNEY DISEASE: AN ANALYTICAL REVIEW. Complex Issues of Cardiovascular Diseases. 2026;15(1):97-108. (In Russ.) https://doi.org/10.17802/2306-1278-2026-15-1-97-108
Views:
175
JATS XML
